Cerebral hemorrhage after systemic fibrinolysis in a patient with severe carotid artery stenosis.

Acta Neurol Scand

Stroke Unit/Neurologische Klinik, Berlin, Germany.

Published: December 1999

Despite the beneficial effect of systemic fibrinolysis in treatment within 3 hours from ischemic stroke onset, the unpredicted occurrence of intracerebral hemorrhage remains a risk from such therapy. Few data exist defining patients at risk for this outcome. We report clinical and neuropathological data on a patient fulfilling NINDS rt-PA study and ECASS-2 inclusion criteria with an acute stroke due to high-grade carotid artery stenosis and preceded by amaurosis fugax. He died from an intracerebral hemorrhage after systemic fibrinolysis. The fatal outcome adds support to recommendations that rapid Doppler-sonographic evaluation of the extra- and intracranial vascular status be undertaken before systemic rt-PA is implemented in acute ischemic stroke.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0404.1999.tb01061.xDOI Listing

Publication Analysis

Top Keywords

systemic fibrinolysis
12
hemorrhage systemic
8
carotid artery
8
artery stenosis
8
ischemic stroke
8
intracerebral hemorrhage
8
cerebral hemorrhage
4
systemic
4
fibrinolysis patient
4
patient severe
4

Similar Publications

(Group A Streptococcus, GAS) is a human pathogen that causes local and systemic infections of the skin and mucous membranes. However, GAS is also found asymptomatically in the nasopharynx of infants. GAS infections, including pharyngitis and invasive pneumosepsis, pose significant public health concerns.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates sex differences in treatment approaches for pulmonary embolism (PE) among older adults, revealing that existing evidence on disparities is limited and often inconclusive due to small sample sizes and inadequate methods.
  • Analysis of data from a European PE registry and US Medicare beneficiaries shows no significant overall sex differences in the use of anticoagulation or advanced therapies, although fewer women received fibrinolytic therapy compared to men with intermediate-risk PE.
  • The authors suggest that future research should explore whether the observed sex disparities in treatment correlate with different clinical outcomes, especially regarding fibrinolytic therapy and advanced treatment utilization in older adults in the US.
View Article and Find Full Text PDF
Article Synopsis
  • The study is a retrospective analysis investigating the effectiveness of single bolus cisternal urokinase in treating patients with saccular aneurysms and subarachnoid hemorrhages from January 2007 to December 2019.
  • It found that administering urokinase during surgical clipping led to better outcomes in terms of reduced vasospasm, lower mortality rates, and fewer permanent CSF diversions compared to endovascular treatment methods, especially in patients with higher Fisher grades.
  • Overall, the findings suggest that this treatment is safe and beneficial without significantly increasing complications like hemorrhages or infections.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the coagulation status of dogs with canine parvoviral enteritis (CPE), a severe condition that can lead to high mortality due to systemic inflammation and multi-organ dysfunction.
  • It involved 21 dogs diagnosed with CPE and 5 healthy controls, using thromboelastography (TEG) to analyze coagulation, showing significant differences in reaction times and clot dissolution rates.
  • The findings suggest that TEG-derived velocity curve (v-curve) parameters could be a better method to assess coagulation in CPE cases, offering new insights for diagnosis and treatment strategies.
View Article and Find Full Text PDF

Disseminated intravascular coagulation (DIC) is an acquired disorder characterized by systemic activation of blood coagulation, which can arise from various causes. Owing to its abrupt onset, rapid progression, and high mortality rate, DIC presents a major clinical challenge. Anticoagulant drugs, such as heparin or low-molecular-weight heparin, are the current gold standard of treatment; however, these interventions pose considerable bleeding risks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!